Vyant Bio Inc reports results for the quarter ended in December - Earnings Summary

Vyant Bio

30/03/2022 14:31

* Vyant Bio Inc  VYNT.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 16 cents per
share.
    * Revenue was $-2.53 million​;  analysts expected $1.59
million. 
    * Vyant Bio Inc's reported EPS for the quarter was a loss
of 4
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vyant Bio Inc shares had held steady so far this quarter.
    * The company reported a quarterly loss of $6.27 million.
    * Wall Street's median 12-month price target for Vyant Bio
Inc is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 30 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated